Zhang Zhi-Kai, Davies Kelvin P, Allen Jeffrey, Zhu Liang, Pestell Richard G, Zagzag David, Kalpana Ganjam V
Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Mol Cell Biol. 2002 Aug;22(16):5975-88. doi: 10.1128/MCB.22.16.5975-5988.2002.
INI1/hSNF5 is a component of the ATP-dependent chromatin remodeling hSWI/SNF complex and a tumor suppressor gene of aggressive pediatric atypical teratoid and malignant rhabdoid tumors (AT/RT). To understand the molecular mechanisms underlying its tumor suppressor function, we studied the effect of reintroduction of INI1/hSNF5 into AT/RT-derived cell lines such as MON that carry biallelic deletions of the INI1/hSNF5 locus. We demonstrate that expression of INI1/hSNF5 causes G(0)-G(1) arrest and flat cell formation in these cells. In addition, INI1/hSNF5 repressed transcription of cyclin D1 gene in MON, in a histone deacetylase (HDAC)-dependent manner. Chromatin immunoprecipitation studies revealed that INI1/hSNF5 was directly recruited to the cyclin D1 promoter and that its binding correlated with recruitment of HDAC1 and deacetylation of histones at the promoter. Analysis of INI1/hSNF5 truncations indicated that cyclin D1 repression and flat cell formation are tightly correlated. Coexpression of cyclin D1 from a heterologous promoter in MON was sufficient to eliminate the INI1-mediated flat cell formation and cell cycle arrest. Furthermore, cyclin D1 was overexpressed in AT/RT tumors. Our data suggest that one of the mechanisms by which INI1/hSNF5 exerts its tumor suppressor function is by mediating the cell cycle arrest due to the direct recruitment of HDAC activity to the cyclin D1 promoter thereby causing its repression and G(0)-G(1) arrest. Repression of cyclin D1 gene expression may serve as a useful strategy to treat AT/RT.
INI1/hSNF5是ATP依赖的染色质重塑hSWI/SNF复合物的一个组成部分,也是侵袭性儿童非典型畸胎瘤和恶性横纹肌样瘤(AT/RT)的一个肿瘤抑制基因。为了了解其肿瘤抑制功能的分子机制,我们研究了将INI1/hSNF5重新导入携带INI1/hSNF5基因座双等位基因缺失的AT/RT来源细胞系(如MON)的效果。我们证明,INI1/hSNF5的表达导致这些细胞出现G(0)-G(1)期阻滞和平坦细胞形成。此外,INI1/hSNF5以组蛋白去乙酰化酶(HDAC)依赖的方式抑制MON中细胞周期蛋白D1基因的转录。染色质免疫沉淀研究表明,INI1/hSNF5被直接招募到细胞周期蛋白D1启动子,其结合与HDAC1的招募以及启动子处组蛋白的去乙酰化相关。对INI1/hSNF5截短体的分析表明,细胞周期蛋白D1的抑制和平坦细胞形成紧密相关。在MON中从异源启动子共表达细胞周期蛋白D1足以消除INI1介导的平坦细胞形成和细胞周期阻滞。此外,细胞周期蛋白D1在AT/RT肿瘤中过表达。我们的数据表明,INI1/hSNF5发挥其肿瘤抑制功能的机制之一是通过将HDAC活性直接招募到细胞周期蛋白D1启动子,从而导致其抑制和G(0)-G(1)期阻滞,进而介导细胞周期阻滞。抑制细胞周期蛋白D1基因表达可能是治疗AT/RT的一种有效策略。